San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Evofem Inc. Raises $25 Million in Series D Round

San Diego biotech Evofem Inc. has raised $25 million in a Series D round.

Tease photo

Craig Kussman Named CFO at Organovo Holdings

Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, has appointed Craig Kussman as chief financial officer.

Sorrento Therapeutics Launches Joint Venture With South Korean Biotech

San Diego drugmaker Sorrento Therapeutics is launching a joint venture with South Korea’s CHA Biotech to develop an anti-cancer therapy. This is the latest in a string of joint ventures Sorrento has created in the last few months.

DJO Global Posts $293 Million in Net Sales for Second Quarter

San Diego medical device maker DJO Global reported a bump to its net sales in the second quarter.

Sequenom Sold in Deal Worth $371 Million

BIOTECH: LabCorp Buys Struggling Diagnostic Co.

San Diego’s Sequenom Inc., which has seen a string of losses in recent years, is being acquired by LabCorp, a giant in the diagnostics and lab testing industry, in a deal worth $371 million.

Tease photo

Rise and Shine

BIOTECH: ResMed’s Efforts In Informatics Pay Off As Company’s Value Climbs

ResMed Inc. is shoring up its position in the “internet of medical things,” funneling massive resources into its digital health portfolio and watching its stock climb as a result.

ResMed Reports Q4 Revenue of $324.5 Million

San Diego device maker ResMed Inc. reported a sizeable jump in revenue both for the company’s fourth quarter and its full 2016 fiscal year.

NuVasive's Healthy Q2 Earnings Beat Wall Street Expectations

Medical device maker NuVasive Inc. reported a significant boost to the company’s sales and revenue for the second quarter, topping Wall Street’s expectations.

Sequenom Acquired by LabCorp for $371 Million

San Diego’s Sequenom Inc. is being acquired by LabCorp, a giant in the diagnostics and lab testing industry, in a deal worth $371 million.

Illumina Reports Q2 Revenue of $600.1 million

San Diego’s medtech giant Illumina Inc. reported Tuesday that its second quarter revenue rose 11 percent.

Organovo Holdings Inc. Moving to Nasdaq Exchange

Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, is moving its stock to the biotech-heavy Nasdaq exchange from the NYSE MKT.

Apricus Biosciences Terminates One Agreement, Signs Another

San Diego biopharma Apricus Biosciences is expanding its exclusive distribution deal with Swiss firm Ferring Pharmaceuticals Inc. and terminating its deal with German drugmaker Sandoz.

Allergan Terminates Agreement With Adamis Pharmaceuticals

Pharmaceutical giant Allergan Plc is backing out of its deal with San Diego-based Adamis Pharmceuticals Corp. to commercialize the firm’s epinephrine pre-filled syringe for the treatment of life-threatening allergic reactions (anaphylaxis).

AristaMD Raises $11 Million in Series A Financing

Local digital health company AristaMD raised $11 million in a Series A financing, the company announced Friday.

UCSD to Open Tokyo Office to Further Japanese Partnerships

The University of California, San Diego is opening an office in downtown Tokyo, where researchers will seek partnerships with Japan’s booming life science industry.